ICD-10 and Oncology – How ICD-10 CM Impacts Cancer Registries – Commission on Cancer Participants

ICD-10 will impact Cancer registries, sometimes called “tumor registries.”

Today these registries rely on ICD-9-CM codes for diagnoses and procedures that are subsequently stored in electronic medical records. Cancer registrars use the ICD-9-CM codes for case finding.   In some states,  disease indices for case finding are dependent on these codes. Medical coding is one of the casef inding primary resources for cancer registrars.

The American College of Surgeons (ACoS) established the Commission on Cancer (CoC) in 1922.  The CoC are designed to ensure quality, multi- disciplinary, comprehensive cancer care delivery.  The CoC conducts health care surveys to assess compliance with standards, and it collects data from accredited providers to measure cancer care quality.

If you are in a CoC hospital registry, you are also collecting complications and co morbidities, which are ICD-9-CM codes.  These codes will be replaced by  ICD-10-CM.

Member organizations in the CoC include:

American Academy of Hospice and Palliative Medicine (AAHPM)

American Academy of Pediatrics (AAP)

American Association for Cancer Education (AACE)

American Cancer Society (ACS)

American College of Obstetricians and Gynecologists (ACOG)

American College of Oncology Administrators (ACOA)

American College of Physicians (ACP)

American College of Radiology (ACR)

American College of Surgeons (ACoS)

American College of Surgeons Committee on Young Surgeons (ACOSCYS)

American College of Surgeons Oncology Group (ACOSOG)

American College of Surgeons Resident and Associate Society (ACOSRAS)

American Dietetic Association (ADA)

American Head and Neck Society (AHNS)

American Hospital Association (AHA)

American Joint Committee on Cancer (AJCC)

American Medical Association (AMA)

American Pediatric Surgical Association (APSA)

American Psychosocial Oncology Society (APOS)

American Radium Society (ARS)

American Society of Breast Surgeons (ASBS)

American Society of Clinical Oncology (ASCO)

American Society of Colon and Rectal Surgeons (ASCRS)

American Society for Radiation Oncology (ASRO)

American Urological Association (AUA)

Association of American Cancer Institutes (AACI)

Association of Cancer Executives (ACE)

Association of Community Cancer Centers (ACCC)

Association of Oncology Social Work (AOSW)

Canadian Society of Surgical Oncology (CSSO)

Centers for Disease Control and Prevention (CDC)

College of American Pathologists (CAP)

Department of Defense (DoD)

Department of Veterans Affairs (VA)

International Union Against Cancer—UICC (IUAC/UICC)

National Cancer Institute: Surveillance, Epidemiology, and End Results (SEER) Program (NCI/SEER)

National Cancer Institute: Outcomes Research

National Cancer Registrars Association (NCRA)

National Comprehensive Cancer Network (NCCN)

National Consortium of Breast Cancer, Inc. (NCBC)

National Society of Genetic Counselors (NSGC)

National Surgical Adjuvant Breast and Bowel Project (NSABP)

North American Association of Central Cancer Registries (NAACCR)

Oncology Nursing Society (ONS)

Society of Gynecologic Oncologists (SGO)

Society of Nuclear Medicine (SNM)

Society of Surgical Oncology (SSO)

Society of Thoracic Surgeons (STS)

Michael F. Arrigo

Michael Arrigo, an expert witness, and healthcare executive, brings four decades of experience in the software, financial services, and healthcare industries. In 2000, Mr. Arrigo founded No World Borders, a healthcare data, regulations, and economics firm with clients in the pharmaceutical, medical device, hospital, surgical center, physician group, diagnostic imaging, genetic testing, health I.T., and health insurance markets. His expertise spans the federal health programs Medicare and Medicaid and private insurance. He advises Medicare Advantage Organizations that provide health insurance under Part C of the Medicare Act. Mr. Arrigo serves as an expert witness regarding medical coding and billing, fraud damages, and electronic health record software for the U.S. Department of Justice. He has valued well over $1 billion in medical billings in personal injury liens, malpractice, and insurance fraud cases. The U.S. Court of Appeals considered Mr. Arrigo's opinion regarding loss amounts, vacating, and remanding sentencing in a fraud case. Mr. Arrigo provides expertise in the Medicare Secondary Payer Act, Medicare LCDs, anti-trust litigation, medical intellectual property and trade secrets, HIPAA privacy, health care electronic claim data Standards, physician compensation, Anti-Kickback Statute, Stark law, the Affordable Care Act, False Claims Act, and the ARRA HITECH Act. Arrigo advises investors on merger and acquisition (M&A) diligence in the healthcare industry on transactions cumulatively valued at over $1 billion. Mr. Arrigo spent over ten years in Silicon Valley software firms in roles from Product Manager to CEO. He was product manager for a leading-edge database technology joint venture that became commercialized as Microsoft SQL Server, Vice President of Marketing for a software company when it grew from under $2 million in revenue to a $50 million acquisition by a company now merged into Cincom Systems, hired by private equity investors to serve as Vice President of Marketing for a secure email software company until its acquisition and multi $million investor exit by a company now merged into Axway Software S.A. (Euronext: AXW.PA), and CEO of one of the first cloud-based billing software companies, licensing its technology to Citrix Systems (NASDAQ: CTXS). Later, before entering the healthcare industry, he joined Fortune 500 company Fidelity National Financial (NYSE: FNF) as a Vice President, overseeing eCommerce solutions for the mortgage banking industry. While serving as a Vice President at Fortune 500 company First American Financial (NYSE: FAF), he oversaw eCommerce and regulatory compliance technology initiatives for the top ten mortgage banks and led the Sarbanes Oxley Act Section 302 internal controls I.T. audit for the company, supporting Section 404 of the Sarbanes Oxley Act. Mr. Arrigo earned his Bachelor of Science in Business Administration from the University of Southern California. Before that, he studied computer science, statistics, and economics at the University of California, Irvine. His post-graduate studies include biomedical ethics at Harvard Medical School, biomedical informatics at Stanford Medical School, blockchain and crypto-economics at the Massachusetts Institute of Technology, and training as a Certified Professional Medical Auditor (CPMA). Mr. Arrigo is qualified to serve as a director due to his experience in healthcare data, regulations, and economics, his leadership roles in software and financial services public companies, and his healthcare M&A diligence and public company regulatory experience. Mr. Arrigo is quoted in The Wall Street Journal, Fortune Magazine, Kaiser Health News, Consumer Affairs, National Public Radio (NPR), NBC News Houston, USA Today / Milwaukee Journal Sentinel, Medical Economics, Capitol ForumThe Daily Beast, the Lund Report, Inside Higher Ed, New England Psychologist, and other press and media outlets. He authored a peer-reviewed article regarding clinical documentation quality to support accurate medical coding, billing, and good patient care, published by Healthcare Financial Management Association (HFMA) and published in Healthcare I.T. News. Mr. Arrigo serves as a member of the board of directors of a publicly traded company in the healthcare and data analytics industry, where his duties include: member, audit committee; chair, compensation committee; member, special committee.

Leave a Reply